ProShare Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.8M Buy
75,985
+3,537
+5% +$978K 0.02% 299
2026
Q1
$21.4M Sell
72,448
-3,525
-5% -$1.05M 0.03% 269
2025
Q4
$20.7M Sell
75,973
-295
-0.4% -$80.2K 0.04% 274
2025
Q3
$20.6M Sell
76,268
-8,263
-10% -$2.25M 0.04% 273
2025
Q2
$23.3M Buy
84,531
+149
+0.2% +$40.5K 0.05% 263
2025
Q1
$22.4M Sell
84,382
-1,328
-2% -$328K 0.05% 257
2024
Q4
$19.9M Buy
85,710
+7,896
+10% +$1.82M 0.05% 256
2024
Q3
$17.2M Sell
77,814
-3,667
-5% -$759K 0.04% 266
2024
Q2
$16M Buy
81,481
+3,477
+4% +$718K 0.04% 263
2024
Q1
$16.8M Sell
78,004
-4,051
-5% -$851K 0.04% 261
2023
Q4
$17.3M Sell
82,055
-4,792
-6% -$1.02M 0.05% 248
2023
Q3
$17.4M Sell
86,847
-2,618
-3% -$520K 0.05% 246
2023
Q2
$16.6M Buy
89,465
+245
+0.3% +$45.3K 0.05% 255
2023
Q1
$17.1M Buy
89,220
+8,258
+10% +$1.49M 0.05% 252
2022
Q4
$13.6M Buy
80,962
+10,266
+15% +$1.78M 0.05% 250
2022
Q3
$12.5M Sell
70,696
-6,599
-9% -$1.3M 0.05% 254
2022
Q2
$15.8M Sell
77,295
-20,984
-21% -$4.45M 0.05% 253
2022
Q1
$23.4M Sell
98,279
-1,673
-2% -$393K 0.05% 239
2021
Q4
$22.8M Buy
99,952
+17,089
+21% +$3.76M 0.04% 233
2021
Q3
$16M Buy
82,863
+3,219
+4% +$652K 0.05% 283
2021
Q2
$16.9M Buy
79,644
+4,930
+7% +$1.04M 0.05% 278
2021
Q1
$15.3M Buy
74,714
+7,727
+12% +$1.52M 0.05% 280
2020
Q4
$12.2M Sell
66,987
-1,346
-2% -$229K 0.05% 277
2020
Q3
$11.4M Sell
68,333
-625
-0.9% -$105K 0.05% 261
2020
Q2
$11.2M Buy
68,958
+6,221
+10% +$1.12M 0.06% 252
2020
Q1
$10.8M Sell
62,737
-42,937
-41% -$8.55M 0.08% 209
2019
Q4
$21.2M Buy
105,674
+15,510
+17% +$3.18M 0.1% 164
2019
Q3
$19.1M Sell
90,164
-298
-0.3% -$62.3K 0.11% 151
2019
Q2
$17.6M Sell
90,462
-21,326
-19% -$3.93M 0.11% 160
2019
Q1
$18.4M Buy
111,788
+1,174
+1% +$208K 0.11% 155
2018
Q4
$20.8M Buy
110,614
+3,644
+3% +$673K 0.15% 129
2018
Q3
$18.2M Sell
106,970
-13,492
-11% -$2.27M 0.12% 138
2018
Q2
$19.7M Buy
120,462
+3,654
+3% +$597K 0.13% 132
2018
Q1
$18.9M Buy
116,808
+11,655
+11% +$1.86M 0.12% 146
2017
Q4
$15.4M Buy
105,153
+20,073
+24% +$2.86M 0.11% 163
2017
Q3
$11.5M Buy
85,080
+2,173
+3% +$275K 0.11% 166
2017
Q2
$10.4M Sell
82,907
-1,785
-2% -$213K 0.1% 179
2017
Q1
$10.1M Buy
84,692
+2,983
+4% +$359K 0.11% 185
2016
Q4
$9.43M Sell
81,709
-210
-0.3% -$23.4K 0.1% 164
2016
Q3
$8.56M Sell
81,919
-11,306
-12% -$1.18M 0.12% 138
2016
Q2
$9.08M Sell
93,225
-4,526
-5% -$428K 0.12% 156
2016
Q1
$9.39M Sell
97,751
-23,280
-19% -$2.12M 0.13% 150
2015
Q4
$11M Buy
121,031
+6,576
+6% +$619K 0.13% 153
2015
Q3
$10.6M Buy
114,455
+10,042
+10% +$955K 0.15% 149
2015
Q2
$9.72M Sell
104,413
-10,438
-9% -$974K 0.13% 160
2015
Q1
$10.9M Sell
114,851
-9,549
-8% -$885K 0.13% 171
2014
Q4
$11M Buy
124,400
+12,436
+11% +$1.05M 0.13% 175
2014
Q3
$8.95M Sell
111,964
-12,063
-10% -$909K 0.12% 165
2014
Q2
$8.8M Buy
124,027
+1,951
+2% +$137K 0.11% 163
2014
Q1
$9.04M Buy
122,076
+15,091
+14% +$1.14M 0.11% 152
2013
Q4
$8.39M Buy
106,985
+27,622
+35% +$2.16M 0.13% 155
2013
Q3
$5.86M Sell
79,363
-17,996
-18% -$1.33M 0.14% 116
2013
Q2
$7.4M Buy
+97,359
New +$6.39M 0.15% 122

Other funds holding CME

ProShare Advisors's CME Position: Q2 2026 in Review

ProShare Advisors increased its CME Group (CME) stake by 4.9% in Q2 2026, buying an estimated $978K and bringing the position to 75,985 shares worth $16.8M. The position accounts for 0.02% of the portfolio, ranked #299.

ProShare Advisors first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $23.4M in Q1 2022. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • ProShare Advisors held 75,985 shares of CME Group worth $16.8M as of Q2 2026.
  • ProShare Advisors bought 3,537 CME Group shares in Q2 2026, an estimated $978K.
  • CME Group made up 0.02% of ProShare Advisors's portfolio in Q2 2026, its #299 holding.
  • ProShare Advisors first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • ProShare Advisors's CME Group position peaked at $23.4M in Q1 2022.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.